Ticagrelor Tablet
Product Images NDC 72205-368

Product Visual Gallery

This gallery contains 25 technical images submitted to the FDA as part of the official labeling for Ticagrelor (NDC 72205-368). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tica-tabs-90mg-1000s-cntnr-label (Tica Tabs 90mg 1000s Cntnr Label)

This is a prescription medication called Ticagrelor, available in tablet form with each tablet containing 90 mg ticagrelor. The usual adult dosage and storage instructions are mentioned in the text. This medication should be kept out of reach of children. Manufacturing details indicate it is produced by MSN Laboratories Private Limited in India, and distributed by Novadoz Pharmaceuticals LLC in Piscataway, NJ. A Medication Guide should be provided to each patient along with the tablets.*

FDA Label Image

Tica-tabs-90mg-100s-cntnr-label (Tica Tabs 90mg 100s Cntnr Label)

This text provides information on Ticagrelor tablets, containing 90 mg of ticagrelor per tablet. The medication guide should be dispensed to each patient with a prescription of 100 tablets. The usual adult dosage and storage instructions are included, along with a warning to keep the medication out of reach of children. The tablets are manufactured by MSN Laboratories Private Limited in India and distributed by Novadoz Pharmaceuticals LLC in Piscataway, NJ. The document also mentions where to print medication guides and provides contact information for Novadoz Pharmaceuticals.*

FDA Label Image

Tica-tabs-90mg-180s-cntnr-label (Tica Tabs 90mg 180s Cntnr Label)

This is an evaluation label for Ticagrelor tablets, containing 90 mg of ticagrelor per tablet. It advises to dispense the accompanying Medication Guide to each patient and provides storage instructions. The manufacturer is MSN Laboratories Private Limited in India, and the distributor is Novadoz Pharmaceuticals LLC in the US. The usual adult dosage information is provided in the package insert. It warns to keep the medication out of the reach of children. The revision date of the label is March 2025.*

FDA Label Image

Tica-tabs-90mg-60s-cntnr-label (Tica Tabs 90mg 60s Cntnr Label)

This is a prescription medicine called Ticagrelor, containing 90 mg of active ingredient per tablet. It is dispensed with a Medication Guide for patient information and instructions. The usual adult dosage information can be found in the package insert. It is important to keep this medication out of the reach of children. Storage instructions recommend keeping it at 25°C (77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). The Medication Guides can be printed online, and the medicine is manufactured by MSN Laboratories in India and distributed by Novadoz Pharmaceuticals in the US. More information can be found at www.NovadozPharma.com/Products.*

FDA Label Image

Tica-tabs-90mg-blister-foil (Tica Tabs 90mg Blister Foil)

FDA Label Image

Tica-tabs-90mg-carton-label (Tica Tabs 90mg Carton Label)

This is a description of a medication package containing 100 Ticagrelor tablets in 10 x 10 unit-dose format. The tablets contain 90 mg of Ticagrelor and are intended for adult use. The package includes a Medication Guide for each patient. The medication should be stored at 25°C (77°F) with permissible excursions between 15°C to 30°C (59°F to 86°F). The package is not intended for bulk dispensing and includes the manufacturer's information for reference.*

FDA Label Image

Tica-tabs-fig-01 (Tica Tabs Fig 01)

FDA Label Image

Tica-tabs-fig-02 (Tica Tabs Fig 02)

FDA Label Image

Tica-tabs-fig-03 (Tica Tabs Fig 03)

FDA Label Image

Tica-tabs-fig-04 (Tica Tabs Fig 04)

FDA Label Image

Tica-tabs-fig-05 (Tica Tabs Fig 05)

FDA Label Image

Tica-tabs-fig-06 (Tica Tabs Fig 06)

FDA Label Image

Tica-tabs-fig-07 (Tica Tabs Fig 07)

FDA Label Image

Tica-tabs-fig-08 (Tica Tabs Fig 08)

This text provides information on the effects and recommended dose adjustments for various medications interacting with CYP3A4 enzymes. It includes details on strong CYP3A4 inhibitors like ketoconazole, moderate inhibitors like diltiazem, potent CYP3A4 inducers like rifampin, and medications affecting P-gP and CYP3A enzymes. The text also mentions specific dosages and adjustments for each drug to avoid potential interactions and ensure optimal efficacy and safety.*

FDA Label Image

Tica-tabs-fig-09 (Tica Tabs Fig 09)

This text provides information on interacting drugs with Ticagrelor and includes details such as the impact of the drug interaction, recommended dose adjustments, and specific medication combinations. It is a valuable resource for healthcare professionals managing patients receiving Ticagrelor in combination with other medications.*

FDA Label Image

Tica-tabs-fig-10 (Tica Tabs Fig 10)

FDA Label Image

Tica-tabs-fig-11 (Tica Tabs Fig 11)

FDA Label Image

Tica-tabs-fig-12 (Tica Tabs Fig 12)

FDA Label Image

Tica-tabs-fig-13 (Tica Tabs Fig 13)

Not available.*

FDA Label Image

Tica-tabs-fig-14 (Tica Tabs Fig 14)

FDA Label Image

Tica-tabs-fig-15 (Tica Tabs Fig 15)

FDA Label Image

Tica-tabs-fig-16 (Tica Tabs Fig 16)

FDA Label Image

Tica-tabs-fig-17 (Tica Tabs Fig 17)

FDA Label Image

Tica-tabs-fig-18 (Tica Tabs Fig 18)

This is a not-available response.*

FDA Label Image

Tica-tabs-structure (Tica Tabs Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.